CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Constraint-induced movement therapyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00057018
NCT00057018Phase 3Completed
CompareCT.gov

The Extremity Constraint Induced Therapy Evaluation (EXCITE) Trial

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·interventional·Posted Mar 28, 2003·Updated Sep 26, 2016

In Brief

A Phase 3 clinical trial evaluating Constraint-induced movement therapy for Cerebrovascular Accident. Completed, across 7 sites.

Detailed Summary

An individual suffering a stroke or other brain injury may lose function on one side of the body (partial paralysis). As the individual shifts activities to favor the unaffected side, the problem worsens. Constraint induced (CI) therapy forces the individual to use the neglected arm by restraining the good arm in a sling. This study examines the effectiveness of CI therapy for improving arm motion after stroke.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebrovascular Accident
CountriesUnited States
CollaboratorsNational Institute of Neurological Disorders and Stroke (NINDS)

Timeline

Phase 3CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 28, 2003
Enrollment StartApr 1, 2000
Primary CompletionMar 1, 2005
Study CompletionJan 1, 2006
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 23.3 years ago

Interventions

Constraint-induced movement therapyprocedure